Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Equity Average (2016 - 2025)

Historic Equity Average for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to $16.2 billion.

  • Fresenius Medical Care AG's Equity Average fell 37.27% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 billion, marking a year-over-year decrease of 37.27%. This contributed to the annual value of $16.4 billion for FY2024, which is 343.11% up from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Equity Average stood at $16.2 billion, which was down 37.27% from $16.3 billion recorded in Q2 2025.
  • Fresenius Medical Care AG's Equity Average's 5-year high stood at $16.7 billion during Q3 2022, with a 5-year trough of $15.3 billion in Q1 2021.
  • For the 5-year period, Fresenius Medical Care AG's Equity Average averaged around $16.2 billion, with its median value being $16.3 billion (2024).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 801.35% in 2021, then plummeted by 139.44% in 2024.
  • Over the past 5 years, Fresenius Medical Care AG's Equity Average (Quarter) stood at $15.9 billion in 2021, then grew by 2.47% to $16.3 billion in 2022, then rose by 0.36% to $16.4 billion in 2023, then rose by 1.03% to $16.5 billion in 2024, then fell by 1.86% to $16.2 billion in 2025.
  • Its Equity Average stands at $16.2 billion for Q3 2025, versus $16.3 billion for Q2 2025 and $16.6 billion for Q1 2025.